SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? (2020)
Attributed to:
Klebsiella anti-immunology: exploiting proteins with a eukaryotic SEFIR domain
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202012560
PubMed Identifier: 32453917
Publication URI: http://europepmc.org/abstract/MED/32453917
Type: Journal Article/Review
Volume: 12
Parent Publication: EMBO molecular medicine
Issue: 7
ISSN: 1757-4676